Clear Cell Carcinoma of the Ovary: A Case Report
Received Date: Nov 09, 2019 / Accepted Date: Dec 17, 2019 / Published Date: Dec 24, 2019
Clear cell carcinomas (CCCs) occur most often in young women (median age: 20 years) even before the first pregnancy. It is essential to be conservative and to respect the genital system as much as possible to preserve ovarian hormonal function and fertility. Mutations in KRAS, BRAF, and TP53 are present in some clear cell carcinomas, but their frequency is generally low. Mutations predicted to deregulate PI3K/PTEN signaling. Because of resistance to the usual platinum and taxane chemotherapies, the advanced stages have a much worse prognosis than that of serous tumors. Thus, some studies have suggested that CCCs may be more sensitive to a combination of irinotecan than paclitaxel-based chemotherapy.
Keywords: Clear cell carcinoma; Ovary; Surgery; Chemotherapy
Citation: Berrada S, Mahdi L, Hassani ME, Kouach J, Moussaoui D (2019) Clear Cell Carcinoma of the Ovary: A Case Report. J Cancer Sci Ther 11: 313-314.
Copyright: © 2019 Berrada S, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Select your language of interest to view the total content in your interested language
Share This Article
April 20-21, 2020 Berlin, Germany
- Total views: 310
- [From(publication date): 0-0 - Apr 08, 2020]
- Breakdown by view type
- HTML page views: 286
- PDF downloads: 24